Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Allogene Therapeutics Inc

Allogene Therapeutics Inc

ALLO · NASDAQ
ALLO · NASDAQ

Next Earnings: 12 Aug 2026

2.00
USD-0.16-7.41%

Latest News

    CoinOtag

    Binance Wallet’s ALLO (RWA) TGE Oversubscribed by 143.77 Times: A New Milestone in Crypto Investments

      CoinOtag

      Unlock ALLO (RWA) TGE Participation with Binance Alpha Points: Join the Event on May 22, 2025!

        CoinOtag

        Binance Wallet to Launch ALLO (RWA) TGE: Subscription Opens May 22, 2025

          @DeItaone
          DeItaone

          Coverage Initiated $ALLO $ALNY $ARWR $BEAM $BMRN $CRSP $IONS $NTLA $VRTX $VTYX https://t.co/HsvywOztkC https://t.co/im5wWXPsjd

            @Benzinga
            Benzinga

            $ARKG Bought - $ALLO $NTLA $VERV Sold - $CLLS $PFE $REGN https://t.co/cYbwjQ5WNr

            Analysts Recommendations

            Bullish

            Buy

            Strong Buy

            Buy

            Hold

            Sell

            Strong Sell

            Day Range

            1.96USD
            2.05USD

            52 Week Range

            0.98USD
            4.46USD

            Market Cap

            690.31MUSD

            lock-imagelock-image

            Get Full Access with Profit PRO

            See which Billionaires own this investment

            About

            General Information

            Type

            Common Stock

            Exchange

            NASDAQ

            Currency Code

            USD

            Currency Name

            US Dollar

            Country Name

            USA

            Country ISO

            US

            ISIN

            US0197701065

            CUSIP

            019770106

            Sector

            Healthcare

            Industry

            Biotechnology

            Fiscal Year End

            December

            IPO date

            -

            Updated At

            -

            Highlights

            PE Ratio

            -

            PEG Ratio

            -

            Book Value

            1.14

            Dividend Share

            -

            Dividend Yield

            -

            Earnings Share

            -0.77

            Wall Street Target Price

            8.35

            EPS Estimate Current Year

            -0.64

            EPS Estimate Next Year

            -0.77

            EPS Estimate Current Quarter

            -0.18

            EPS Estimate Next Quarter

            -0.165

            Most Recent Quarter

            -

            Profitability

            Revenue TTM

            0

            Gross Profit TTM

            -131,955,000

            EBITDA

            -175,704,992

            Profit Margin

            0.00%

            Return On Assets TTM

            -25.97%

            Return On Equity TTM

            -52.32%

            Revenue Per Share TTM

            0

            Qtly Revenue Growth YOY

            -100.00%

            Diluted Eps TTM

            -0.77

            Qtly Earnings Growth YOY

            0.00%

            Valuation

            Trailing PE

            0.00

            Forward PE

            0

            Price Sales TTM

            7784.3633

            Price Book MRQ

            2.4753

            Enterprise Value Revenue

            3859

            Enterprise Value EBITDA

            -1

            Peers analysis

            • Be
              ONCBeiGene, Ltd.

              310.25

              1.88%
            • Alnylam Pharmaceuticals Inc
              ALNYAlnylam Pharmaceuticals Inc

              297.45

              1.40%
            • Revolution Medicines Inc
              RVMDRevolution Medicines Inc

              151.56

              1.36%
            • Regeneron Pharmaceuticals Inc
              REGNRegeneron Pharmaceuticals Inc

              638.88

              -10.36%
            • CSL Limited
              CMXHFCSL Limited

              70.00

              -4.83%
            • UCB SA
              UCBJFUCB SA

              270.35

              -4.22%
            • Vertex Pharmaceuticals Inc
              VRTXVertex Pharmaceuticals Inc

              434.52

              -3.57%
            • argenx NV ADR
              ARGXargenx NV ADR

              806.46

              -1.86%
            • CSL Ltd
              CSLLYCSL Ltd

              17.65

              -1.12%
            • UCB SA ADR
              UCBJYUCB SA ADR

              139.99

              -0.67%
            XM

            Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

            Trade with a Trusted, Award-Winning Broker.

            Trading involves risk. The value of investments may go up or down. Trade responsibly.

            FAQs

            What is Allogene Therapeutics stock price today?

            What is Allogene Therapeutics stock ticker?

            Is ALLO stock price going up?

            What is the analyst recommendation for ALLO?

            What is ALLO market cap?

            Does ALLO release financial reports?

            When is ALLO next earnings date?

            What were ALLO Earnings for the last quarter?

            What was ALLO Revenue for the last quarter?

            What was ALLO Net Income for the last quarter?

            Does ALLO pay dividends?

            How many employees does ALLO have?

            What is ALLO EBITDA?

            How to buy ALLO stocks?

            Should I invest in ALLO stock?